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1LITERATURE REVIEW
Proteins that regulate follicular growth and response to gonadotropins have
recently been found in bovine follicular fluid (FF). A clearer understanding of
those regulators could result in increased reproductive efficiency. Recently,
researchers have investigated the biochemical makeup of the protein regulators and
their mechanisms affecting foUiculogenesis. However, this area of study is new
and the physiological mechanisms proposed are speculative. Since this area of
research is relatively new, literature pertaining specifically to gonadotropin
inhibitors at the ovarian level is not extensive. Thus, this review is intended to
point out the specific research that has led to the physiological studies of
biologically active factors in follicular fluid that inhibit ovarian follicular response
to follicle stimulating hormone (FSH), and to determine if those factors have a
physiological role in controlling the estrous cycle.
Ovarian follicles do not respond equally to similar cyclic hormonal
conditions which suggests that individual follicles have their own regulators
(Richards and Midgley, 1976). Maturation of antral follicles appears to be
dependent on FSH and maturing follicles show an increase in receptors for
luteinizing hormone (LH) in granulosa cells, an elevated secretion of estradiol, and
a high ratio of estrogens to androgens. Atresia in antral follicles is associated with
a decrease in granulosa cell receptors for both LH and FSH with smaller estrogen
to androgen ratios (Ireland and Roche, 1983; Sluss et al, 1983). Some of these
follicular changes may be internally regulated while others may be externally
regulated. The presence of inhibin in FF and its ability to suppress FSH secretion
is well documented. Injections of FF lowered serum FSH levels in ovariectomized
heifers (Kiracofe et al., 1983) intact bulls (McGowan et al., 198^) and adult male
rats (Sheth et al., 1983). Sato et al. (1982) injected FF in unilaterally
ovariectomized mice and decreased serum FSH levels and compensatory ovarian
hypertrophy. These researchers cited inhibin as the proteinaceous compound
responsible for their experimental results. However, not all follicular changes can
be explained by the level of FSH secretion. Sluss and Reichert (1983) found that
FF inhibited attachment of FSH to its binding sites in both granulosa cells and
homogenates of calf testis. This factor does not appear to be inhibin. The
molecular weight of inhibin as determined by gel electrophoresis is around 19,000
(Sheth et al., 1983) while the fractionated portion of FF that suppressed FSH
binding to its receptor sites had a molecular weight of less than 5000 (Reichert et
al., 1982).
Isolation of an FSH binding inhibitor (FSH-BI) has been accomplished and
determined to be a protein after fractionation, heat treatment, charcoal extraction
and exposure to trypsin (Sluss et al., 1983; Sato et al., 1980; Kalla and Zarabi,
198^^).
Concentration of FSH-BI is highest in pools of fluid from cows in the luteal
phase of their estrous cycle with small luteal follicles «10mm) having a higher
concentration than larger luteal follicles (Sluss et al., 1983). There is a high
correlation (r=.97) between FSH-BI concentration and the relative degree of
follicular atresia (Sluss and Reichert, 1983). Immunohistochemical studies carried
out by Sato et al
.
(1982) indicate the inhibitor is located in the granulosa cells.
Other evidence supports a physiological role for FF proteins in the
regulation of reproductive function. Dizerga et al . (1983) referred to an inhibition
of aromatase activity and interference with folliculogenesis in monkeys following
FF treatment. Miller et al. (1979) reported injections of steroid extracted FF
interrupted the sequence of normal follicular development in sheep and cattle.
These data are consistent with those of Sato et al. (1982) and indicate that
follicles containing the inhibitor may be prevented from progressing further in
development.
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INTRODUCTION
Improved reproductive efficiency in the bovine, in many cases, is dependent on a
clearer understanding of ovarian foiiicular growth and maturation. Some factors have
been identified in bovine follicular fluid (FF) that might control follicular maturation.
Follicular fluid contains a factor capable of delaying estrus in prostaglandin treated
cows (1) and suppressing follicle stimulating hormone (FSH) in serum of ovariectomized
heifers (2) and intact bulls (3). These effects have been attributed to a protein called
inhibin, which influences pituitary secretion of FSH. In addition to inhibin, a low
molecular weight protein «6,000) has been isolated from bovine FF which inhibits jn
v^tro binding of FSH in homogenates of calf testis W. This FSH binding inhibitor
(FSH-BI) prevented compensatory ovarian hypertrophy in mice and inhibited binding of
FSH to granulosa cells jn vitro (5). Concentration of the FSH-BI appears to be
correlated with the physiological state of the follicle W.
Since bovine FSH-BI could be a major factor in regulating ovarian follicular
maturation, it is essential that further evidence for its existence be shown. Data are
available which suggest a non-steroidal factor in FF interferes with pituitary control
of follicular growth, but little information exists for one that works at the ovarian
level. The present experiments tested the ability of bovine ovarian FF to affect the
ovarian weights of prepuberal rats given bFSH and human chorionic gonadotropin (hCG).
MATERIALS AND METHODS
Collection of Follicular Fluid
Reproductive tracts were obtained from mature cows as they were slaughtered at
Jack Polen Beef Packers, Kansas City, KS. The horns of each tract were incised and
pregnancy determined by the presence of a conceptus. If no conceptus was present,
stage of the estrous cycle was determined by the presence or absence of a corpus
luteum (CD that appeared functional. Ovaries with functional CL were classified luteal
while ovaries with atretic CL were classified follicular. Follicular diameters were
measured with a ruler pressed against the follicle. Those with an antrum greater than
8mm in diameter were classified large and those 8mm or less were classified small.
Fluid from ovarian follicles was aspirated using a syringe and an 18 gauge
hypodermic needle. Fluid was then divided into six pools according to classification of
the reproductive tract and follicles: pregnant large, pregnant small, follicular large,
follicular small, luteal large, and luteal small. The pools of fluid were kept on ice until
frozen (-20C) approximately 8 hours later. The FF was thawed just before use and
refrigerated at approximately 5C during the injection period.
Blood Serum, Hormones and Animals
Serum used for injection in all trials was obtained from four beef heifers bled by
jugular venipuncture. Purified bovine FSH (USDA-b-FSH-B-1) was generously provided
by Dr. Douglas Bolt, USDA, Beltsville, MD. The hCG was a commercial preparation
(Ayerst Laboratories, New York, NY). The bFSH and hCG were dissolved in
physiological saline and mixed to provide the appropriate dose in a .2ml injection.
Twenty-two day old female Sprague Dawley rats were obtained from Hilltop
Laboratories, Scottdale, PA. The rats were kept in an environmentally controlled room
with 12 hours light and 12 hours dark with feed and water available ad libitum. All
rats were 23 days old at the start of each trial and 26 days old when sacrificed.
7Trial 1
In the first trial, 'fS rats were utilized in a Steelman-Pohley bioassay (6). Four
levels of FSH were administered. Each level was given in 9 sc injections with rats
receiving a total of either 0, 30, 60, or 120ug bPSH/l.Sml. A total of 20IU of hCG was
administered along with the bPSH in the 9 injections. The hormone combination was
given in .2ml per injection. Twelve rats were assigned to each of the 4 hormone levels
with half of the rats in each hormone level receiving pooled (large and small) bovine
luteal FF in a .3ml sc injection at each of the 9 injection periods. The other half
received a sc injection of .3ml bovine blood serum. Therefore, each rat was injected
twice at each of the 9 injection periods. All pools of FF were assayed for FSH-BI and
results are reported in another paper W. Luteal phase FF was used in this study
because FSH-BI activity was highest in our luteal fluid pools. Rats were injected every
8 hours for 3 days. Eight hours after the last injection, the rats were killed with
chloroform. Weights were taken on each animal, then their reproductive tract was
removed. Using a dissecting scope with 6x magnification, the uterus and ovaries were
trimmed of adnexal tissues with care being taken to keep the ovaries moist. Weights
were then obtained for the paired ovaries and for the uterus using a torsion balance.
Trial 2
The second trial was a repetition of the first except for the addition of a 90ug
bFSH group. This trial utilized 60 rats in 5 hormone treatment levels: 0, 30, 60, 90, and
120ug bFSH with a total of 20IU hCG in each level. Weights of rats and paired ovarian
weights were recorded.
Trial 3
The third trial utilized 2l^ rats, equally divided into groups. Each group
received the same level of hormone (30 ug bFSH plus 20 lU hCG) in 9 sc injections of
.2ml. In addition, group 1 received non-extracted luteal FF, group 2 received charcoal
sextracted FF, group 3 received bovine blood serum and group ^ received saline. All
blood serum and FF injections were in .3ml at each of the 9 injection periods. The FF
was extracted with charcoal by mixing 50mg of charcoal per ml of FF, stirring for 1
hour at room temperature, centrifuging for 1 hour at 9,000xG at 5C, then filtering the
supernatant through .l^5um filter paper. Weights of rats and paired ovarian weights
were taken 8 hours following the last injection period.
Trial »
Ninety-six rats were divided into 2 hormone treatments with ^ subtreatments in
each group. The 2 hormone levels used were 30ug bFSH plus 20IU hCG and 60ug bFSH
plus 20IU hCG. Within the 30ug bFSH group, ^ treatments were administered: .15ml FF,
.3ml FF, .^5ml FF and .3ml bovine blood serum. In the 60ug bFSH group the four
treatments were: .3ml FF, .^5ml FF, .6ml FF and .3ml bovine blood serum. All FF used
was from a pool of luteal phase ovarian follicles. The injection schedule and data
collection were as described in trial 1.
Statistics
Data from Trial 1 and 2 were pooled and analyzed using Statistical Analysis
Systems (SAS) two-way analysis of variance. Trial 3 data were analyzed using SAS
one-way analysis of variance and Trial * using one-way analysis of covariance (7).
RESULTS AND DISCUSSION
Trials 1 and 2
Overall, rats injected with non-extracted bovine luteal FF had lighter ovarian
weights compared to those injected with bovine blood serum (P<.006). Although
ovarian weights of FF treated rats were consistently lighter than those from serum
injected rats, a significant treatment effect was observed only within rats treated with
30 ug bFSH (Table 1). In the original Steelman-Pohley bioassay, levels up to 200ug
9bFSH plus 20IU hCG resulted in a linear increase in ovarian weight. Our results show a
linear response in ovarian weight until the 90 ug bFSH level, where it increased rapidly.
This erratic response may have been due to increased potency of bFSH which is
currently available compared with that utilized in the original Steelman-Pohley assay.
Uterine weights were not significantly different between levels. Uterine weights were
taken as an indicator of estrogen stimulation (8). However, since average uterine
weights were not different (serum = 156.5 + 20.25mg, FF = 155.5 35.39mg), and
appeared to be maximally stimulated by the bFSH-hCG treatment, they were not taken
in subsequent trials.
Trial 3
Non-extracted bovine luteal FF was not significantly different than charcoal
extracted bovine FF in its ability to suppress ovarian weight (P<.39) indicating that
steroid hormones present in FF were not responsible for the ovarian weight suppression
(Table 2). This agrees with data from Miller et al. attributing FSH binding activity to a
non-steroidal substance. It has been shown that charcoal extraction does remove all
radioimmunoassayable estrogens (2). Although not significantly different, ovarian
weights from rats injected with charcoal extracted FF tended to be lower than those
from nonextracted FF treated rats. This could be due to the extraction procedure
taking out granulosa cells and other cellular debris, thus concentrating FSH-BI in the
extracted FF compared with the nonextracted FF.
Bovine blood serum and physiological saline did not differ in their affect on
ovarian weights (P<.5) indicating that the normal constituents of serum were not
contributing to alterations in ovarian weights (Table 3). Previous reports that
progesterone suppressed compensatory ovarian hypertrophy of unilaterally
ovariectomized rats (9) and the well-known estrogen suppression of bFSH prompted an
investigation of the affect of hormone levels in our bovine blood serum on ovarian
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Table 1
EFFECT OF BOVINE FOLLICULAR FLUID ON
OVARL\N WEIGHT OF PREPUBERAL RATS
GIVEN bFSH AND hCG
FSH(ug/rat)^ TREATMENT OVARIAN WT(mg)*^ P VALUE
S *9.08 0.*7
FF **.33
30 S 67.75 .01
30 FF 50.75
60 S 73.33 0.18
60 FF 6^^.50
90 S 79.12 0.3*
90 FF 70.29
120 S 10*.75 0.44
120 FF 99.67
Each rat edso received 20 lU hCG.
Least square means + standard error of 4.6mg for 12 rats
in each group except the 90ug F5H groups which had 6 rats each.
TABLE 2
COMPARISON OF NONEXTRACTED AND CHARCOAL EXTRACTED
FOLLICULAR FLUID (FF) ON OVARIAN WEIGHT
OF PREPUBERAL RATS GIVEN bFSH AND hCG
TYPE OF FF OVARIAN WEIGHT^ P VALUE
NONEXTRACTED 59.*
0.39
EXTRACTED 52.6
Least square mean + standard error of 5Amg for 6 rats in
each group.
TABLE 3
COMPARISON OF PHYSIOLOGICAL SALINE AND BOVINE
BLOOD SERUM ON OVARIAN WEIGHT OF PREPUBERAL
RATS GIVEN bFSH AND hCG
TREATMENT OVARIAN WEIGHT^ P VALUE
SALINE 61.1
0.50
SERUM 58.9
Least square means + standard error of 5Amg for
6 rats in each group..
r12
weights.
Trial »
Treatment with FF, at both levels of bFSH, significantly suppressed ovarian
weights below that of serum controls (Table k). In the 30 ug bFSH level, ovarian weights
were the same for both .3ml and .*5ml FF injections (*7mg). In Trial 1 and 2, hCG
alone increased ovarian weight to 46.7mg suggesting that maximum suppression of
ovarian weight was reached by injections of .3ml and .45ml FF. Although not
significant between levels of FF, increasing doses of FF tended to result in lighter
subsequent ovarian weights. These data suggest that FSH-BI could be competing with
FSH for binding sites in the granulosa cells. By increasing the number of FSH-BI
molecules, more FSH is displaced and ovarian follicular growth is decreased. Variations
of ovarian weights between trials, given the same hormone and FF treatment, are most
likely due to different concentrations of the FSH-BI in particular pools of fluid.
There appears to be little doubt that FF contains an FSH-BI that can decrease
the biological effectiveness of circulating FSH. Several modes of action of the FSH-BI
have been proposed. One such method is by an inhibition of aromatase activity, thereby
reducing levels of estradiol and interfering with folliculogenesis (10). In Trial 1, uterine
weights were not affected by FF injections, therefore, it would appear that FF had no
dramatic effect on estradiol activity.
A second method proposed is that the FSH-BI protein molecule inhibits binding of
FSH to its receptor site (4,11). Our data supports and extends this theory and suggests
that binding may be competitive in nature.
It has been suggested that secretion of inhibin by granulosa cells is suppressed as
ovulation approaches (12). This suppression brings about a wave of FSH that might be
responsible for inducing maturation of a new set of follicles. We propose that FSH-BI
plays a role in tying up FSH binding sites so that existing follicles become atretic and
few follicles are allowed to grow and mature. Inhibin may also be suppressed by this
mechanism. Additional information is needed on the concentration of FSH-BI in
individual follicles throughout the estrous cycle to test this hypothesis.
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TABLE 4
EFFECT OF VARYING LEVELS OF BOVINE FOLLICULAR
FLUID (FF) ON OVARIAN WEIGHTS OF PREPUBERAL RATS
PRIMED WITH bFSH AND hCG
FSH(ug/rat)^ FF(ml)'* OVARIAN WT(mg)*^ P VALUE^
0.0 68.5
0.15 53.8 0.006
30 0.3 47.3 0.0001
0.45 47.6 0.0001
0.0 78.3
0.3 60.3 0.0009
60 0.45 58.7 0.0003
0.6 52.4 0.0001
^ Each rat also received 20IU hCG.
The zero group received .3ml bovine blood serum. Numbers
represent the amount of FF given at each of the 9 injection periods.
Least square means +^ standard error of 3.7mg for 12 rats in
each group.
Different than serum treatment within the respective FSH level.
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CHANGES IN FSH-BI CONCENTRATION IN FOLLICULAR FLUID DURING
THE ESTROUS CYCLE OF THE BEEF HEIFER
INTRODUCTION
Recently, the role of proteins in follicular fluid (FF) has been intensely
investigated. Biochemical and histochemical studies have eluded to the existence of
an FSH-BI that works at the ovarian level in granulosa cells 11). Suppression
of utilization of follicle stimulating hormone (F5H) by the ovary has also been
attributed to the proteinaceous FSH-binding inhibitor (FSH-BI) (13). However, all
the data accumulated to date was derived from pools of FF. Data evaluating
concentrations of FSH-BI in individual follicles is not available.
Follicular maturation is associated with an increased concentration of
receptors for luteinizing hormone (LH) in granulosa cells and a dramatic increase in
the ratio of estrogens to androgens in FF. Atresia in antral follicles corresponds
with a decrease in the number of granulosa cell receptors for both LH and FSH,
with a decrease in the estrogen to androgen ratio (4).
As follicles near ovulation, estrogen active (E-A) and estrogen inactive (E-I)
follicles appear to be equally distributed. In E-A follicles, binding of FSH
decreases but granulosa cell numbers increase (H). Within the follicle, FSH-BI
could play a role in regulation of the estrous cycle. The purpose of this study was
to measure FSH-BI concentrations in FF of individual follicles during the estrous
cycle of the heifer, particularly just before and after the ovulatory release of LH
and ovulation.
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MATERIALS AND METHODS
Forty three 18-month old crossbred heifers housed in dry lot at the Kansas
State University Beef Research Unit were visually checked for standing estrus twice
daily. Only heifers showing two overt estrous periods 18-22 days apart were
selected for the experiment. An intramuscular injection of 30mg of prostaglandin
(dinoprost tromethamine; Lutalyse, The Upjohn Co., Kalamazoo, MI) was
administered to all heifers in an attempt to synchronize estrus. On day 8 of a
subsequent cycle (estrus = day 0), heifers were assigned to one of five groups: (1)
ovariectomy (OVX) on day 8, (2) largest follicle marked with charcoal (injected in
stroma around follicle) on day 8 then OVX on day 11, (3) prostaglandin injection on
day 8 and if no estrus OVX 42 hours later, W prostaglandin injection on day 8
then OVX 12 hours after the subsequent standing estrus, and (5) prostaglandin
injection on day 8 then OVX 4 days after the subsequent estrus. Immediately after
surgical removal of ovaries, follicles were measured two-dimensionally and their
fluid aspirated with a syringe and 20 gauge needle. Fluid from follicles larger than
5mm in diameter were identified by size and stored separately while fluid from
smaller follicles was pooled. A tissue sample from the wall of the largest follicle
of each heifer was removed and stored in Bouins solution. All corpora lutea (CL)
were examined and if an antrum was present it was measured and the fluid
aspirated and stored separately. All FF samples were frozen at -20C until analysis.
One blood sample was taken by jugular venipuncture before each surgery
from the five heifers in group 1 and from the 5 heifers in group 2. All heifers in
group 3, 4, and 5 were injected imtramuscularly with 30mg of lutalyse on day 8
and were observed for estrus every 6 hours until OVX. No signs of estrus were
observed before OVX at 42 hours in the five heifers in group 3. Blood was
collected just before prostaglandin injection and then at 12, 24, 36 and 42 hours
after prostaglandin.
Six heifers in group * were OVX approximately 12 hours after standing
estrus. Blood was collected immediately before the prostaglandin injection, at 12,
2^ and 36 hours after prostaglandin then every 6 hours until OVX.
Five heifers in group 5 were OVX * days after estrus. Blood collection was
the same as in group 4 except samples were taken once daily after estrus until
OVX. All blood samples were centrifuged within 2'^ hours of collection at 2500xG
for 20 minutes and the serum filtered off and stored by heifer number and
collection time. Blood serum from all animals was frozen and stored at -20C until
radioimmunoassayed for FSH and LH by Dr. Douglas Bolt, USDA, Beltsville, MD. The
frozen FF and follicle wall samples were shipped to Drs. Leo Reichert and Pat
Sluss in the Albany Medical School, Albany, NY for determination of FSH-BI
concentration and estrogen :androgen ratios.
Results
Analysis of concentrations of LH in serum indicated that no heifers in group
1, 2, or 3 had ovulatory surges of LH before OVX. Four of the 6 heifers in group
4 had LH surges before OVX, but non had ovulated at OVX. All of the heifers in
group 5 had an ovulatory surge and had ovulated before OVX.
A dominant follicle was present in all day 8 OVX heifers along with a
well-formed CL. The largest follicle in all heifers in group 2 was positioned next
to the functional CL with no apparent change in size over the next 3 days.
Concentrations of FSH in the serum of those heifers remained unchanged from day
8 to day 11 and ranged from 11 to 22ng/ml. Perhaps circulating levels of FSH of
this magnitude can keep follicles from decreasing in size.
Heifers OVX in group 3 had an easily discernable dominant follicle, as did
heifers in group ^. In addition, group ^ heifers had fewer follicles over 6mm than
group 3. It would seem that as ovulation approaches, the dominant follicle is the
only one to increase in size and fluid content while the others regress. This
agrees with findings by Ireland and Roche (1^).
Heifers in group 5 (OVX 4 days after estrus) had many antral follicles
present on their ovaries. All had a functional new CL but the majority of the
largest follicles were contralateral to the CL which was different than the
observation of follicles at day 8.
In heifers in which two prostaglandin injections were used to synchronize
their estrus and day 8 injection, respectively, the majority had a fluid filled
antrum in their CL. Analysis of this and all the FF gathered from all stages in
the heifers cycles is currently being carried out. Concentration of FSH-BI will be
correlated between stages of the cycle (Groups 1, 2, and 5) and before and after
the LH surge (Groups 3 and 4). Follicular wall samples will be observed
histologically for granulosa cell numbers which will also be correlated to stage of
the cycle and FSH-BI.
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Follicular fluid (FF) was collected from ovarian follicles of nonpregnant
slaughtered cows. Fluid was aspirated from follicles on ovaries classified as luteal
by the gross appearance of the corpus luteum. Four Steelman-Pohley bioassays for
follicle stimulating hormone (FSH) were conducted utilizing 228, 23 day old
prepuberal Sprague-Dawley rats to test the effect of FF on the bioassay. In the
first two assays, pooled FF was tested for the presence of an F5H-binding
inhibitor (F5H-BI), utilizing 108 rats. In the first assay, each rat received 20 lU of
human chorionic gonadotropin (hCG), pooled with either 0, 30, 60, or 120 ug of
bFSH in saline. The total amount of hormone was administered in nine .2ml sc
injections given 8 hours apart and 12 rats were assigned to each dose level of
bFSH. Half of the rats in each bFSH dose level also received a .3ml sc injection of
bovine blood serum at each injection period, while the other half received a .3ml
sc injection of the pooled luteal FF. The second assay was a replicate of the first,
except that a 90ug bFSH dose level was added. All rats were killed and weighed 8
hours after the last injection. Both ovaries were removed, freed of adnexal tissues
and weighed to the nearest mg. Results of the two assays were pooled. Paired
ovarian weights from rats receiving 0, 30, 60, 90, and 120 ug of bFSH plus blood
serum were 49, 67, 73, 78, and 104 mg, respectively, while ovaries from the rats
receiving the same levels of bFSH plus FF averaged 44, 50, 64, 70, and 99 mg,
respectively. Ovarian weight within the 30ug dose of bFSH was lower (P<.02) in
rats injected with FF than in those injected with blood serum, but no significant
differences were found at the other bFSH levels. When all 108 rats were
considered, those injected with FF had lighter (P<.006) ovaries than those injected
with blood serum. These results indicate that bovine FF contains a factor capable
of reducing the biological action of bFSH on the ovary, possibly by inhibiting FSH
binding.
In a third assay, l^i- rats all received a total of 30ug bFSH plus 20IU hCG in
nine .2ml injections given eight hours apart. Rats were divided into ^ equal groups
and received an additional .3ml injection at each of the 9 injection periods of
either: (1) charcoal extracted bovine FF, (2) non-extracted bovine FF, (3)
physiological saline, or (4) bovine blood serum. Ovarian weights were similar for
rats injected with charcoal extracted FF and non-extracted FF (P<.39) and for
those injected with saline and blood serum (P<.5). Results of this assay indicate
the factor suppressing ovarian weights was not a steroid and was not present in
blood serum in concentrations high enough to have an effect.
The fourth assay involved 96 rats with half receiving 30 ug bFSH plus 20IU
hCG and the other half receiving 60 ug bFSH plus 20IU hCG given as in the first 3
assays. Four additional treatments were administered to the 30ug FSH group: (1)
.3ml bovine blood serum, (2) .15ml luteal FF, (3) .3ml luteal FF, and (4) .^5ml
luteal FF. The four additional treatments administered to the 60ug FSH group
were: (1) .3ml bovine blood serum, (2) .3ml luteal FF, (3) .45ml luteal FF, and (4)
.6ml luteal FF. All FF treatments significantly suppressed ovarian weights
compared to their respective serum control. Although not significant in all cases,
the higher the volume of FF administered, the more suppression obtained. Results
indicate the FSH-BI protein could be competitively binding FSH receptor sites on
the granulosa cells.
